2-hydroxychavicol has been researched along with Pancreatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guha Majumdar, A; Subramanian, M | 1 |
1 other study(ies) available for 2-hydroxychavicol and Pancreatic Neoplasms
| Article | Year |
|---|---|
Hydroxychavicol from Piper betle induces apoptosis, cell cycle arrest, and inhibits epithelial-mesenchymal transition in pancreatic cancer cells.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Eugenol; HEK293 Cells; Humans; Pancreatic Neoplasms; Piper betle; Plant Extracts | 2019 |